Kyocera Corporation today announced that its U.S. headquarters, Kyocera International, Inc., has finalized an agreement with Renovis Surgical Technologies, Inc. to purchase the major assets of Renovis’ business operations relating to artificial joint and spinal products.
January 16, 2019
· 3 min read